What is a good levonorgestrel (progestin) and ethinyl estradiol (estrogen) combination for someone with a history of Polycystic Ovary Syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levonorgestrel-Ethinyl Estradiol for PCOS

For women with PCOS who are not attempting to conceive, a combined oral contraceptive containing 30-35 μg ethinyl estradiol with levonorgestrel (such as 0.15 mg levonorgestrel/0.03 mg ethinyl estradiol) is an excellent first-line choice, as recommended by the American Academy of Family Physicians. 1

Why This Combination Works for PCOS

Combined oral contraceptives (COCs) are the first-line medication treatment for long-term management of PCOS in women not attempting pregnancy because they address multiple pathophysiologic mechanisms 1:

  • Suppress androgen secretion by the ovaries, directly targeting the hyperandrogenism characteristic of PCOS 1
  • Increase sex hormone-binding globulin (SHBG), which further reduces free testosterone levels 1
  • Reduce endometrial cancer risk, which is elevated in PCOS due to chronic anovulation and unopposed estrogen exposure 1
  • Improve hirsutism and acne, common concerns in PCOS patients 2, 1

Specific Formulation Recommendations

Levonorgestrel-containing COCs are particularly appropriate for PCOS because many adolescent medicine providers begin with a COC containing 30-35 μg ethinyl estradiol and a progestin such as levonorgestrel or norgestimate 2. The evidence supports this approach:

  • Desogestrel 0.15 mg/ethinyl estradiol 0.03 mg (which metabolizes to etonogestrel, similar to levonorgestrel) demonstrated significant improvements in hirsutism, free and total testosterone levels, and SHBG in PCOS patients after 8 months of treatment 3
  • Lower-dose formulations (20 μg ethinyl estradiol) are equally effective at reducing androgens compared to 30 μg formulations in PCOS patients 4
  • Levonorgestrel has minimal androgenic activity, making it suitable for hyperandrogenic conditions like PCOS 2

Dosing and Initiation Protocol

Starting the Medication

If started within the first 5 days of menstrual bleeding, no additional contraceptive protection is needed 2, 1. However, many PCOS patients have oligomenorrhea or amenorrhea, so:

  • For patients with infrequent menses: Start at any time if reasonably certain the patient is not pregnant 1
  • Use backup contraception for the first 7 days when starting outside the first 5 days of bleeding 2, 1

Standard Regimen

  • 21-24 hormone pills followed by 4-7 placebo pills in a 28-day pack 2, 1
  • Monophasic formulations (same dose in each active pill) are preferred for simplicity 2
  • Take one pill daily at the same time each day 5

Extended or Continuous Cycles

Consider extended or continuous cycles for PCOS patients with severe dysmenorrhea, heavy bleeding, or anemia 2:

  • Eliminates hormone-free intervals, optimizing ovarian suppression 2
  • Reduces menstrual-related symptoms 2
  • Most common adverse effect is unscheduled bleeding 2

Managing Missed Pills

If one pill is missed (<24 hours late):

  • Take the missed pill as soon as remembered 2
  • Continue regular schedule 2

If two consecutive pills are missed in Week 1 or 2:

  • Take 2 pills the day remembered and 2 pills the next day 2, 5
  • Use backup contraception for 7 days 2, 5

If two consecutive pills are missed in Week 3 or three or more pills missed anytime:

  • Continue taking one pill daily until Sunday (for Sunday start) 5
  • Discard the rest of the pack on Sunday and start a new pack 5
  • Use backup contraception for 7 days 5

Important Clinical Considerations

Cardiovascular Risk

The baseline risk of venous thromboembolism (VTE) in reproductive-age women is approximately 1 per 10,000 woman-years, and COCs increase this risk three to fourfold 1. However:

  • COCs remain safe throughout a woman's reproductive years with appropriate screening 2
  • Screen for VTE risk factors before prescribing 2
  • Completely reversible with no negative effect on long-term fertility 2, 1

Metabolic Monitoring

All women with PCOS should be screened for metabolic complications 1:

  • Fasting glucose and 2-hour glucose tolerance test for type 2 diabetes 1
  • Fasting lipoprotein profile for dyslipidemia 1

Noncontraceptive Benefits

Beyond treating PCOS, these formulations provide 2, 1:

  • Decreased menstrual cramping and blood loss 2, 1
  • Improvement in acne 2, 1
  • Protection against endometrial and ovarian cancers with >3 years use 2

When COCs Are Not Appropriate

If contraception is contraindicated or not tolerated, use cyclic progestin alone 1:

  • Medroxyprogesterone acetate 10 mg daily for 12-14 days per month to induce withdrawal bleeding and provide endometrial protection 1
  • Oral micronized progesterone 200 mg daily for 12-14 days per month as an alternative with superior safety profile 1

Common Pitfalls to Avoid

  • Don't delay treatment waiting for "perfect" metabolic control—weight loss of even 5% improves PCOS outcomes, but medication can be started concurrently 1
  • Don't use progestins with anti-androgenic effects alone in PCOS patients with sexual dysfunction, as they may worsen hypoandrogenism 2
  • Don't forget endometrial protection—PCOS patients with chronic anovulation require either COCs or cyclic progestin to prevent endometrial hyperplasia 1
  • Counsel about expected bleeding patterns to improve adherence, as irregular bleeding is common initially 2

References

Guideline

First-Line Medication Treatment for Polycystic Ovarian Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Comparison of two contraceptive pills containing drospirenone and 20 μg or 30 μg ethinyl estradiol for polycystic ovary syndrome.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.